Table 2.
Bartter | Gitelman | Liddle | AME | Geller | Congenital Adrenal Hyperplasia | Familial Hyperaldosteronism | |
---|---|---|---|---|---|---|---|
Potassium | Low | Low | Low | Low | Low | Low | Normal or Low |
Sodium Bicarbonate | High | High | High | High | High | High | High |
Renin | High | High | Low | Low | Low | Low | Low |
Aldosterone | High | High | Low | Low | Low | Low | High |
Hypertension | No | No | Yes | Yes | Yes | Yes | Yes |
Cortisol/ACTH | − | − | − | N/N | − | Low/High | |
Age of onset | Infancy | Childhood/Adulthood | Childhood/Adulthood | Every age | Adulthood | Infancy | Childhood/Adulthood |
Transmission | AD-AR | AR | AD | AR | AD | AD | AD |
Alteration | NaKCl cotransporter 2 Renal outer medullary K channel Cl channel Barttin Ca sensing receptor | NaCl cotransporter Cl channel Kb |
Epithelial Na channel gain of function | Defect in11-beta-hydroxysteroid dehydrogenase type 2 | Gain of function mutation of mineralocorticoid receptor | Steroid synthesis defect with gain of function of mineralocorticoid receptor | Increased levels of 18-oxocortisol and 18-hydroxycortisol |
Gene | SLC12A1 KCNJ1 CLCNKB BSND CASR | SLC12A3 CLCNKB |
SCNN1B SCNN1G |
HSD11B2 | NR3C2 | CYP21A2 | CYP11B1/CYP11B2 CLCN2 KCNJ5 CACNA1H |
AME: apparent excess of mineralcorticoid; ACTH: adreno cortico tropin hormone; N: normal; AR: autosomic recessive; AD: autosomic dominant.